Uncategorized

Decentralized Clinical Trials (DCTs) Market Trends and Forecast Report 2022-2028: by Players, Types, Applications and Regions

The Global and United States Decentralized Clinical Trials (DCTs) Market Report was published by QY Research recently.

 

Decentralized Clinical Trials (DCTs) Market Analysis and Insights

This report focuses on global and United States Decentralized Clinical Trials (DCTs) market, also covers the segmentation data of other regions in regional level and county level.

 

Decentralized Clinical Trials (DCTs) market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Decentralized Clinical Trials (DCTs) market will be able to gain the upper hand as they use the report as a powerful resource.

 

For United States market, this report focuses on the Decentralized Clinical Trials (DCTs) market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.

 

Access full Report Description, Table of Figure, Chart, Free sample, etc. please click

https://us.qyresearch.com/reports/162017/decentralized-clinical-trials-dcts

 

Decentralized Clinical Trials (DCTs) Market Segment by Type

Interventional Trials

Observational Trials

Expanded Access Trials

 

Decentralized Clinical Trials (DCTs) Market Segment by Application

Oncology

Cardiovascular Disease

Others

 

The report on the Decentralized Clinical Trials (DCTs) market covers the following region analysis:

North America

Europe

Asia-Pacific

Latin America

Middle East & Africa

 

The report mentions the prominent market player consisting of:

ICON Plc

LEO Innovation Lab

Science 37

PRA Health Sciences

Clinical Ink

Parexel

Medable

Oracle

CRF Health

Medidata

Covance

IQVIA

PPD

PWNHealth, LLC

Medrio

 

Key Benefits:

To study and analyze the global Decentralized Clinical Trials (DCTs) consumption (value & volume) by key regions/countries, type and application, history data from 2017 to 2022, and forecast to 2028.

To understand the structure of Decentralized Clinical Trials (DCTs) market by identifying its various subsegments.

Focuses on the key global Decentralized Clinical Trials (DCTs) manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.

To analyze the Decentralized Clinical Trials (DCTs) with respect to individual growth trends, prospects, and their contribution to the total market.

To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges, and risks).

To project the consumption of Decentralized Clinical Trials (DCTs) submarkets, with respect to key regions (along with their respective key countries).

To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

To strategically profile the key players and comprehensively analyze their growth strategies.

 

Key Topics Covered

1 Study Coverage

2 Market by Type

3 Market by Application

4 Global Decentralized Clinical Trials (DCTs) Competitor Landscape by Company

5 Global Decentralized Clinical Trials (DCTs) Market Size by Region
5.1 Global Decentralized Clinical Trials (DCTs) Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Decentralized Clinical Trials (DCTs) Market Size in Volume by Region (2017-2028)
5.2.1 Global Decentralized Clinical Trials (DCTs) Sales in Volume by Region: 2017-2022
5.2.2 Global Decentralized Clinical Trials (DCTs) Sales in Volume Forecast by Region (2023-2028)
5.3 Global Decentralized Clinical Trials (DCTs) Market Size in Value by Region (2017-2028)
5.3.1 Global Decentralized Clinical Trials (DCTs) Sales in Value by Region: 2017-2022
5.3.2 Global Decentralized Clinical Trials (DCTs) Sales in Value by Region: 2023-2028

6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Decentralized Clinical Trials (DCTs) Market Size YoY Growth 2017-2028
6.1.2 North America Decentralized Clinical Trials (DCTs) Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 United States
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Decentralized Clinical Trials (DCTs) Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Decentralized Clinical Trials (DCTs) Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 China Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.3 Europe
6.3.1 Europe Decentralized Clinical Trials (DCTs) Market Size YoY Growth 2017-2028
6.3.2 Europe Decentralized Clinical Trials (DCTs) Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Decentralized Clinical Trials (DCTs) Market Size YoY Growth 2017-2028
6.4.2 Latin America Decentralized Clinical Trials (DCTs) Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.4.6 Colombia
6.5 Middle East and Africa
6.5.1 Middle East and Africa Decentralized Clinical Trials (DCTs) Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Decentralized Clinical Trials (DCTs) Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 UAE

7 Company Profiles
7.1 ICON Plc
7.1.1 ICON Plc Company Details
7.1.2 ICON Plc Business Overview
7.1.3 ICON Plc Decentralized Clinical Trials (DCTs) Introduction
7.1.4 ICON Plc Revenue in Decentralized Clinical Trials (DCTs) Business (2017-2022)
7.1.5 ICON Plc Recent Development
7.2 LEO Innovation Lab
7.2.1 LEO Innovation Lab Company Details
7.2.2 LEO Innovation Lab Business Overview
7.2.3 LEO Innovation Lab Decentralized Clinical Trials (DCTs) Introduction
7.2.4 LEO Innovation Lab Revenue in Decentralized Clinical Trials (DCTs) Business (2017-2022)
7.2.5 LEO Innovation Lab Recent Development
7.3 Science 37
7.3.1 Science 37 Company Details
7.3.2 Science 37 Business Overview
7.3.3 Science 37 Decentralized Clinical Trials (DCTs) Introduction
7.3.4 Science 37 Revenue in Decentralized Clinical Trials (DCTs) Business (2017-2022)
7.3.5 Science 37 Recent Development
7.4 PRA Health Sciences
7.4.1 PRA Health Sciences Company Details
7.4.2 PRA Health Sciences Business Overview
7.4.3 PRA Health Sciences Decentralized Clinical Trials (DCTs) Introduction
7.4.4 PRA Health Sciences Revenue in Decentralized Clinical Trials (DCTs) Business (2017-2022)
7.4.5 PRA Health Sciences Recent Development
7.5 Clinical Ink
7.5.1 Clinical Ink Company Details
7.5.2 Clinical Ink Business Overview
7.5.3 Clinical Ink Decentralized Clinical Trials (DCTs) Introduction
7.5.4 Clinical Ink Revenue in Decentralized Clinical Trials (DCTs) Business (2017-2022)
7.5.5 Clinical Ink Recent Development
7.6 Parexel
7.6.1 Parexel Company Details
7.6.2 Parexel Business Overview
7.6.3 Parexel Decentralized Clinical Trials (DCTs) Introduction
7.6.4 Parexel Revenue in Decentralized Clinical Trials (DCTs) Business (2017-2022)
7.6.5 Parexel Recent Development
7.7 Medable
7.7.1 Medable Company Details
7.7.2 Medable Business Overview
7.7.3 Medable Decentralized Clinical Trials (DCTs) Introduction
7.7.4 Medable Revenue in Decentralized Clinical Trials (DCTs) Business (2017-2022)
7.7.5 Medable Recent Development
7.8 Oracle
7.8.1 Oracle Company Details
7.8.2 Oracle Business Overview
7.8.3 Oracle Decentralized Clinical Trials (DCTs) Introduction
7.8.4 Oracle Revenue in Decentralized Clinical Trials (DCTs) Business (2017-2022)
7.8.5 Oracle Recent Development
7.9 CRF Health
7.9.1 CRF Health Company Details
7.9.2 CRF Health Business Overview
7.9.3 CRF Health Decentralized Clinical Trials (DCTs) Introduction
7.9.4 CRF Health Revenue in Decentralized Clinical Trials (DCTs) Business (2017-2022)
7.9.5 CRF Health Recent Development
7.10 Medidata
7.10.1 Medidata Company Details
7.10.2 Medidata Business Overview
7.10.3 Medidata Decentralized Clinical Trials (DCTs) Introduction
7.10.4 Medidata Revenue in Decentralized Clinical Trials (DCTs) Business (2017-2022)
7.10.5 Medidata Recent Development
7.11 Covance
7.11.1 Covance Company Details
7.11.2 Covance Business Overview
7.11.3 Covance Decentralized Clinical Trials (DCTs) Introduction
7.11.4 Covance Revenue in Decentralized Clinical Trials (DCTs) Business (2017-2022)
7.11.5 Covance Recent Development
7.12 IQVIA
7.12.1 IQVIA Company Details
7.12.2 IQVIA Business Overview
7.12.3 IQVIA Decentralized Clinical Trials (DCTs) Introduction
7.12.4 IQVIA Revenue in Decentralized Clinical Trials (DCTs) Business (2017-2022)
7.12.5 IQVIA Recent Development
7.13 PPD
7.13.1 PPD Company Details
7.13.2 PPD Business Overview
7.13.3 PPD Decentralized Clinical Trials (DCTs) Introduction
7.13.4 PPD Revenue in Decentralized Clinical Trials (DCTs) Business (2017-2022)
7.13.5 PPD Recent Development
7.14 PWNHealth, LLC
7.14.1 PWNHealth, LLC Company Details
7.14.2 PWNHealth, LLC Business Overview
7.14.3 PWNHealth, LLC Decentralized Clinical Trials (DCTs) Introduction
7.14.4 PWNHealth, LLC Revenue in Decentralized Clinical Trials (DCTs) Business (2017-2022)
7.14.5 PWNHealth, LLC Recent Development
7.15 Medrio
7.15.1 Medrio Company Details
7.15.2 Medrio Business Overview
7.15.3 Medrio Decentralized Clinical Trials (DCTs) Introduction
7.15.4 Medrio Revenue in Decentralized Clinical Trials (DCTs) Business (2017-2022)
7.15.5 Medrio Recent Development

 

For More Information About This Report, Please Enter:

https://us.qyresearch.com/reports/162017/decentralized-clinical-trials-dcts

Any doubts and questions will be welcome.

 

About Us:

QYResearch founded in California, USA in 2007. It is a leading global market research and consulting company. With over 15 years’ experience and professional research team in various cities over the world, QY Research focuses on management consulting, database and seminar services, IPO consulting, industry chain research and customized research to help our clients in providing non-linear revenue model and make them successful. We are globally recognized for our expansive portfolio of services, good corporate citizenship, and our strong commitment to sustainability. Up to now, we have cooperated with more than 59,000 clients across five continents. Let’s work closely with you and build a bold and better future.

 

Contact Us

QY Research

E-mail: [email protected]

Tel: +1-626-842-1666(US)   +852-5808-0956 (HK)

Add: 17890 Castleton Street Suite 369 City of Industry CA 91748 United States

Website: https://us.qyresearch.com

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button